{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:23:16Z","timestamp":1789129396061,"version":"build-2803163510"},"reference-count":251,"publisher":"Elsevier","isbn-type":[{"value":"9780443415470","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005298","name":"Universidad de Costa Rica","doi-asserted-by":"publisher","award":["817-C5\\u2013253"],"award-info":[{"award-number":["817-C5\\u2013253"]}],"id":[{"id":"10.13039\/501100005298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2020\\u2013118859GB-I00"],"award-info":[{"award-number":["PID2020\\u2013118859GB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2021\\u2013128720NB-100"],"award-info":[{"award-number":["PID2021\\u2013128720NB-100"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apha.2026.02.005","type":"book-chapter","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:10:56Z","timestamp":1772885456000},"page":"257-323","source":"Crossref","is-referenced-by-count":1,"title":["Brain delivery of lipid nanoparticles with shuttle peptides"],"prefix":"10.1016","author":[{"given":"Noelia","family":"Martinez-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Carrera-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hern\u00e1ndez-Munain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Su\u00f1\u00e9-Pou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Su\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1515\/ntrev-2021-0115","article-title":"Approved and marketed nanoparticles for disease targeting and applications in COVID-19","volume":"10","author":"Abdellatif","year":"2021","journal-title":"Nanotechnology Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/pharmaceutics16030329","article-title":"Navigating thefke: A systematic review on lipid-based nanocarriers for central nervous system disorders","volume":"16","author":"Agosti","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jconrel.2020.11.021","article-title":"Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics","volume":"330","author":"Akhtar","year":"2021","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.apha.2026.02.005_bib4","article-title":"Exploring the landscape of lipid nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids","volume":"8","author":"Alfutaimani","year":"2024","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"24","key":"10.1016\/bs.apha.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1021\/acschemneuro.1c00540","article-title":"Engineered solid lipid nanoparticles and nanostructured lipid carriers as new generations of blood-brain barrier transmitters","volume":"12","author":"Amiri","year":"2021","journal-title":"ACS Chemical Neuroscience"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/2211738507666190925112942","article-title":"Scalable manufacturing processes for solid lipid nanoparticles","volume":"7","author":"Anderluzzi","year":"2019","journal-title":"Pharmaceutical Nanotechnology"},{"key":"10.1016\/bs.apha.2026.02.005_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/polym14040712","article-title":"Angiopep-2-modified nanoparticles for brain-directed delivery of therapeutics: A review","volume":"14","author":"Andrade","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/bs.apha.2026.02.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120011","article-title":"Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer\u2019s disease","volume":"591","author":"Arduino","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.005_bib9","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acschemneuro.0c00076","article-title":"GLUT-1: An effective target to deliver brain-derived neurotrophic factor gene across the blood brain barrier","volume":"11","author":"Arora","year":"2020","journal-title":"ACS Chemical Neuroscience"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.nano.2013.12.001","article-title":"Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect A beta aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease","volume":"10","author":"Bana","year":"2014","journal-title":"Nanomedicine"},{"issue":"34","key":"10.1016\/bs.apha.2026.02.005_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202402935","article-title":"Concepts and approaches to reduce or avoid protein corona formation on nanoparticles: Challenges and opportunities","volume":"11","author":"Barz","year":"2024","journal-title":"Advanced Science"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/17425247.2012.673278","article-title":"Lipid nanoparticles: State of the art, new preparation methods and challenges in drug delivery","volume":"9","author":"Battaglia","year":"2012","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17425247.2018.1429401","article-title":"Lipid nanoparticles for intranasal administration: Application to nose-to-brain delivery","volume":"15","author":"Battaglia","year":"2018","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.apha.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3390\/pharmaceutics16121533","article-title":"A comprehensive review of the latest trends in spray freeze drying and comparative insights with conventional technologies","volume":"16","author":"Bordiga","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-food-030713-092354","article-title":"Nanodelivery of bioactive components for food applications: Types of delivery systems, properties, and their effect on ADME profiles and toxicity of nanoparticles","volume":"5","author":"Borel","year":"2014","journal-title":"Annual Review of Food Science and Technology"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib17","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/acsbiomaterials.0c00743","article-title":"Effect of nanoparticle composition, size, shape, and stiffness on penetration across the blood-brain barrier","volume":"6","author":"Brown","year":"2020","journal-title":"ACS Biomaterials Science and Engineering"},{"issue":"41","key":"10.1016\/bs.apha.2026.02.005_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202404234","article-title":"Lipid nanoparticles: Versatile drug delivery vehicles for traversing the blood brain barrier to treat brain cancer","volume":"34","author":"Cai","year":"2024","journal-title":"Advanced Functional Materials"},{"key":"10.1016\/bs.apha.2026.02.005_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124163","article-title":"Is it advantageous to use quality by design (QbD) to develop nanoparticle-based dosage forms for parenteral drug administration?","volume":"657","author":"Camacho Vieira","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102131","article-title":"Anti-miRNA103\/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage","volume":"35","author":"Cepparulo","year":"2024","journal-title":"Molecular Therapy Nucleic Acids"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.34172\/apb.2020.021","article-title":"Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery","volume":"10","author":"Chauhan","year":"2020","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.apsb.2017.11.012","article-title":"Surface modification of PGP for a neutrophil\u2013nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein","volume":"8","author":"Chen","year":"2018","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-025-02426-1","article-title":"Rapid amyloid-\u03b2 clearance and cognitive recovery through multivalent modulation of blood\u2013brain barrier transport","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib24","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1021\/acsnano.2c02084","article-title":"Quantification of available ligand density on the surface of targeted liposomal nanomedicines at the single-particle level","volume":"16","author":"Chen","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/bs.apha.2026.02.005_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2024.09.005","article-title":"Current state of nanomedicine drug products: An industry perspective","author":"Clogston","year":"2024","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"17","key":"10.1016\/bs.apha.2026.02.005_bib26","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1039\/D1CS00707F","article-title":"How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?","volume":"51","author":"Cong","year":"2022","journal-title":"Chemical Society Reviews"},{"key":"10.1016\/bs.apha.2026.02.005_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114485","article-title":"Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood\u2013brain barrier (BBB) to manage neurological disorders","volume":"189","author":"Correia","year":"2022","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.005_bib28","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1080\/17425247.2023.2274902","article-title":"Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery","volume":"20","author":"Correia","year":"2023","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/bs.apha.2026.02.005_bib29","unstructured":"Cost comparison - pharmacoeconomic review report: patisiran (Onpattro) - NCBI Bookshelf. (n.d.). Retrieved 9\u00a0October\u00a02024\u00a0from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549695\/."},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib31","article-title":"Lipid nanoparticles for nasal\/intranasal drug delivery","volume":"34","author":"Cunha","year":"2017","journal-title":"Critical Reviews\u2122 in Therapeutic Drug Carrier Systems"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"s 5\u20136","key":"10.1016\/bs.apha.2026.02.005_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/znc-2023-0181","article-title":"Unveiling the potential of chitosan-coated lipid nanoparticles in drug delivery for management of critical illness: A review","volume":"79","author":"Das","year":"2024","journal-title":"Zeitschrift fur Naturforschung - Section C Journal of Biosciences"},{"issue":"640","key":"10.1016\/bs.apha.2026.02.005_bib34","article-title":"Advances in the functionalization of vaccine delivery systems: Innovative strategies and translational perspectives","volume":"17","author":"de Moura","year":"2025","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-023-03901-8","article-title":"Advances in functional lipid nanoparticles: From drug delivery platforms to clinical applications","volume":"14","author":"Dhayalan","year":"2024","journal-title":"3 Biotech"},{"issue":"44","key":"10.1016\/bs.apha.2026.02.005_bib36","doi-asserted-by":"crossref","first-page":"17254","DOI":"10.1039\/C7NR06437C","article-title":"An apolipoprotein-enriched biomolecular corona switches the cellular uptake mechanism and trafficking pathway of lipid nanoparticles","volume":"9","author":"Digiacomo","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/bs.apha.2026.02.005_bib37","unstructured":"Dilliard, S. A., Cheng, Q., Siegwart, D. J., & Desimone, J. (n.d.). On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. https:\/\/doi.org\/10.1073\/pnas.2109256118\/-\/DCSupplemental."},{"issue":"August","key":"10.1016\/bs.apha.2026.02.005_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","article-title":"Overcoming blood\u2013brain barrier transport: Advances in nanoparticle-based drug delivery strategies","volume":"37","author":"Ding","year":"2020","journal-title":"Materials Today"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13346-022-01262-y","article-title":"Nanomedicines and nanocarriers in clinical trials: Surfing through regulatory requirements and physico-chemical critical quality attributes","volume":"13","author":"Dri","year":"2023","journal-title":"Drug Delivery and Translational Research"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nano.2012.05.015","article-title":"Effect of ligand density, receptor density, and nanoparticle size on cell targeting","volume":"9","author":"Elias","year":"2013","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","article-title":"Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies","volume":"29","author":"Elmowafy","year":"2021","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/bs.apha.2026.02.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124962","article-title":"Rabies virus-mimicking liposomes for targeted gene therapy in Alzheimer\u2019s disease","volume":"668","author":"Erel-Akbaba","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/bs.apha.2026.02.005_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108342","article-title":"Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies","volume":"72","author":"E\u015f","year":"2024","journal-title":"Biotechnology Advances"},{"key":"10.1016\/bs.apha.2026.02.005_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103041","article-title":"Biological recognition and cellular trafficking of targeted RNA-lipid nanoparticles","volume":"85","author":"Escalona-Rayo","year":"2024","journal-title":"Current Opinion in Biotechnology"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.201700375","article-title":"State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery","volume":"2","author":"Evers","year":"2018","journal-title":"Small Methods"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Accounts of Chemical Research"},{"key":"10.1016\/bs.apha.2026.02.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113642","article-title":"Analytical characterization of liposomes and other lipid nanoparticles for drug delivery","volume":"192","author":"Fan","year":"2021","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/bs.apha.2026.02.005_bib48","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/IJN.S231479","article-title":"Overcoming the blood\u2013brain barrier: Successes and challenges in developing nanoparticle-mediated drug delivery systems for the treatment of brain tumours","volume":"15","author":"Ferraris","year":"2020","journal-title":"International Journal of Nanomedicine"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib49","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The biomolecular corona of lipid nanoparticles for gene therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjugate Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/pharmaceutics16040481","article-title":"Nasal delivery to the brain: Harnessing nanoparticles for effective drug transport","volume":"16","author":"Gandhi","year":"2024","journal-title":"Pharmaceutics"},{"issue":"May","key":"10.1016\/bs.apha.2026.02.005_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.scp.2017.07.002","article-title":"Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery","volume":"6","author":"Ganesan","year":"2017","journal-title":"Sustainable Chemistry and Pharmacy"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/pharmaceutics6040557","article-title":"Smuggling drugs into the brain: An overview of ligands targeting transcytosis for drug delivery across the blood\u2013brain barrier","volume":"6","author":"Georgieva","year":"2014","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib54","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Research in Pharmaceutical Sciences"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.005_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071999","article-title":"Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood\u2013Brain Barrier (BBB)","volume":"15","author":"Ghorai","year":"2023","journal-title":"Pharmaceutics"},{"issue":"23","key":"10.1016\/bs.apha.2026.02.005_bib56","doi-asserted-by":"crossref","first-page":"13216","DOI":"10.1021\/acs.chemrev.4c00251","article-title":"Click chemistry for biofunctional polymers: From observing to steering cell behavior","volume":"124","author":"Ghosal","year":"2024","journal-title":"Chemical Reviews"},{"key":"10.1016\/bs.apha.2026.02.005_bib57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcis.2023.12.165","article-title":"Evolution of the structure of lipid nanoparticles for nucleic acid delivery: From in situ studies of formulation to colloidal stability","volume":"660","author":"Gilbert","year":"2024","journal-title":"Journal of Colloid and Interface Science"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.005_bib58","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle\u2013mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nature Biotechnology"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib59","doi-asserted-by":"crossref","DOI":"10.1021\/cr400166n","article-title":"Combinatorial Peptide Libraries: Mining for Cell-Binding Peptides","volume":"114","author":"Gray","year":"2013","journal-title":"Chem Rev"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3897\/pharmacia.70.e98838","article-title":"Drug delivery to the brain \u2013 lipid nanoparticles-based approach","volume":"70","author":"Gugleva","year":"2023","journal-title":"Pharmacia"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041184","article-title":"Key design features of lipid nanoparticles and electrostatic charge-based lipid nanoparticle targeting","volume":"15","author":"Gyanani","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.apha.2026.02.005_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.pedhc.2021.04.001","article-title":"Methodological analysis: Randomized controlled trials for pfizer and moderna COVID-19 vaccines","author":"Hallas","year":"2021","journal-title":"Journal of Pediatric Health Care"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib64","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bioactmat.2020.08.017","article-title":"Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer\u2019s disease mice","volume":"6","author":"Han","year":"2021","journal-title":"Bioactive Materials"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40580-023-00385-3","article-title":"Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy","volume":"10","author":"Han","year":"2023","journal-title":"Nano Convergence"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib66","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Letters"},{"key":"10.1016\/bs.apha.2026.02.005_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2024.1360302","article-title":"Receptor-mediated transcytosis for brain delivery of therapeutics: Receptor classes and criteria","volume":"4","author":"Haqqani","year":"2024","journal-title":"Frontiers in Drug Delivery"},{"key":"10.1016\/bs.apha.2026.02.005_bib68","article-title":"Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery","volume":"8","author":"Haque","year":"2024","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-023-00569-y","article-title":"Pharmacokinetics of nanoparticles: Current knowledge, future directions and its implications in drug delivery","volume":"9","author":"Haripriyaa","year":"2023","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.005_bib70","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.addr.2007.08.044","article-title":"Protein nanoparticles as drug carriers in clinical medicine","volume":"60","author":"Hawkins","year":"2008","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.apha.2026.02.005_bib71","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.102536","article-title":"Solid lipid nanoparticles (SLN)","author":"Hern\u00e1ndez-Esquivel","year":"2022","journal-title":"Nanocomposite Materials for Biomedical and Energy Storage Applications"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.005_bib72","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Molecular Therapy Methods and Clinical Development"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.005_bib74","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nature Reviews Materials"},{"issue":"22","key":"10.1016\/bs.apha.2026.02.005_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303266","article-title":"Physiological barriers and strategies of lipid-based nanoparticles for nucleic acid drug delivery","volume":"36","author":"Hu","year":"2024","journal-title":"Advanced Materials"},{"key":"10.1016\/bs.apha.2026.02.005_bib76","article-title":"Unlocking the therapeutic applicability of LNP-mRNA: Chemistry, formulation, and clinical strategies","volume":"7","author":"Huang","year":"2024","journal-title":"Research; a Journal of Science and its Applications"},{"key":"10.1016\/bs.apha.2026.02.005_bib77","article-title":"Pharmaceutical development Q8","volume":"8","author":"ICH","year":"2009","journal-title":"ICH Harmonised Tripartite Guideline"},{"issue":"16","key":"10.1016\/bs.apha.2026.02.005_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169361","article-title":"Lipid nanoparticles: Promising treatment approach for parkinson\u2019s disease","volume":"23","author":"Jagaran","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2026.02.005_bib79","article-title":"Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and Resveratrol to Alzheimer\u2019s disease: Synthesis, in vitro characterization and brain uptake analysis","volume":"86","author":"Jain","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030281","article-title":"Nanotechnology to overcome blood\u2013brain barrier permeability and damage in neurodegenerative diseases","volume":"17","author":"Jim\u00e9nez","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010131","article-title":"Chemistry and art of developing lipid nanoparticles for biologics delivery: Focus on development and scale-up","volume":"16","author":"John","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib82","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2019.01.005","article-title":"Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo","volume":"295","author":"Johnsen","year":"2019","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.apha.2026.02.005_bib83","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejpb.2018.09.012","article-title":"Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy","volume":"132","author":"Kadari","year":"2018","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121681","article-title":"Carbohydrate anchored lipid nanoparticles","volume":"618","author":"Kakade","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.005_bib85","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1567201816666191029122740","article-title":"Drug delivery and targeting to the brain through nasal route: Mechanisms, applications and challenges","volume":"16","author":"Kashyap","year":"2019","journal-title":"Current Drug Delivery"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib86","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2173333","article-title":"Development of an apolipoprotein E mimetic peptide-lipid conjugate for efficient brain delivery of liposomes","volume":"30","author":"Kato","year":"2023","journal-title":"Drug Deliv"},{"key":"10.1016\/bs.apha.2026.02.005_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2021.127529","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers of natural products as promising systems for their bioactivity enhancement: The case of essential oils and flavonoids","volume":"630","author":"Katopodi","year":"2021","journal-title":"Colloids and Surfaces A: Physicochemical and Engineering Aspects"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib88","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/acs.bioconjchem.4c00293","article-title":"Lipid nanoparticles for brain tumor theranostics: Challenges and status","volume":"35","author":"Kaur","year":"2024","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/bs.apha.2026.02.005_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2021.08.016","article-title":"Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles","volume":"338","author":"Keck","year":"2021","journal-title":"Journal of Controlled Release"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib90","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/pharmaceutics14091886","article-title":"Review on the scale-up methods for the preparation of solid lipid nanoparticles","volume":"14","author":"Khairnar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid nanoparticle-mediated drug delivery to the brain","volume":"197","author":"Khare","year":"2023","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00896-3","article-title":"Protein nanoparticles in drug delivery: Animal protein, plant proteins and protein cages, albumin nanoparticles","volume":"19","author":"Kianfar","year":"2021","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib93","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/nmt-2018-0033","article-title":"Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis","volume":"9","author":"Kristen","year":"2019","journal-title":"Neurodegenerative Disease Management"},{"key":"10.1016\/bs.apha.2026.02.005_bib94","series-title":"Nanocarriers for Drug Delivery","first-page":"249","article-title":"Lipid-based nanoparticles for drug-delivery systems","author":"Kumar","year":"2019"},{"key":"10.1016\/bs.apha.2026.02.005_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103526","article-title":"Lipid based nanocarriers: Production techniques, concepts, and commercialization aspect","volume":"74","author":"Kumar","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib96","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/btpr.2214","article-title":"Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy","volume":"32","author":"Kuo","year":"2016","journal-title":"Biotechnology Progress"},{"key":"10.1016\/bs.apha.2026.02.005_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtice.2022.104394","article-title":"Suppressed XIAP and cIAP expressions in human brain cancer stem cells using BV6- and GDC0152-encapsulated nanoparticles","volume":"135","author":"Kuo","year":"2022","journal-title":"Journal of the Taiwan Institute of Chemical Engineers"},{"issue":"42","key":"10.1016\/bs.apha.2026.02.005_bib98","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1039\/D4AY00821A","article-title":"Folic acid-conjugated long circulating co-encapsulated atorvastatin and quercetin solid lipid nanoparticles: Pharmacokinetics and biodistribution in rats","volume":"16","author":"Lalchandani","year":"2024","journal-title":"Analytical Methods"},{"key":"10.1016\/bs.apha.2026.02.005_bib99","first-page":"305","article-title":"Achieving long-term stability of lipid nanoparticles: Examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Lball","year":"2017","journal-title":"International Journal of Nanomedicine"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.005_bib100","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Experimental & Molecular Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib101","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/nnm.14.204","article-title":"Controlling ligand density on nanoparticles as a means to enhance biological activity","volume":"10","author":"Lee","year":"2015","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"key":"10.1016\/bs.apha.2026.02.005_bib102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jiec.2022.03.043","article-title":"Flow reactor for preparation of lipid nanoparticles via temperature variations","volume":"112","author":"Lesov","year":"2022","journal-title":"Journal of Industrial and Engineering Chemistry"},{"key":"10.1016\/bs.apha.2026.02.005_bib103","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","article-title":"Composition design and medical application of liposomes","volume":"164","author":"Li","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.005_bib104","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1039\/D2TB02455A","article-title":"Optimal delivery strategies for nanoparticle-mediated mRNA delivery","volume":"11","author":"Li","year":"2023","journal-title":"Journal of Materials Chemistry B"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib105","article-title":"Payload distribution and capacity of mRNA lipid nanoparticles","volume":"13","author":"Li","year":"2022","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib106","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1080\/10717544.2022.2075986","article-title":"Targeting interleukin-13 receptor \u03b12 (IL-13R\u03b12) for glioblastoma therapy with surface functionalized nanocarriers","volume":"29","author":"Liang","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/bs.apha.2026.02.005_bib107","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2147\/IJN.S450853","article-title":"Nanoparticle-based combinational strategies for overcoming the blood-brain barrier and blood-tumor barrier","volume":"19","author":"Lim","year":"2024","journal-title":"International Journal of Nanomedicine"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib108","doi-asserted-by":"crossref","first-page":"255","DOI":"10.52601\/bpr.2023.230022","article-title":"Surface engineering of lipid nanoparticles: Targeted nucleic acid delivery and beyond","volume":"9","author":"Lin","year":"2023","journal-title":"Biophysics Reports"},{"issue":"25","key":"10.1016\/bs.apha.2026.02.005_bib109","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12951-025-03415-w","article-title":"Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood\u2013brain barrier permeability","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/bs.apha.2026.02.005_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121645","article-title":"An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy","volume":"287","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/bs.apha.2026.02.005_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202106580","article-title":"Microfluidic nanoparticles for drug delivery","volume":"18","author":"Liu","year":"2022","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/bs.apha.2026.02.005_bib113","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3762\/bjnano.11.72","article-title":"Key for crossing the BBB with nanoparticles: The rational design","volume":"11","author":"Lombardo","year":"2020","journal-title":"Beilstein Journal of Nanotechnology"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"Journal of Biomedical Science"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib115","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/pharmaceutics16091112","article-title":"Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells","volume":"16","author":"Lubitz","year":"2024","journal-title":"Pharmaceutics"},{"issue":"30","key":"10.1016\/bs.apha.2026.02.005_bib116","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4429","article-title":"Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection","volume":"6","author":"Ma","year":"2020","journal-title":"Science Advances"},{"key":"10.1016\/bs.apha.2026.02.005_bib117","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery","volume":"344","author":"Maeki","year":"2022","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-54178-7","article-title":"Co-sonicated coacervation for high-efficiency green nanoencapsulation of phytosterols by colloidal non-biotoxic solid lipid nanoparticles","volume":"14","author":"Mahdlou","year":"2024","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib119","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/08982104.2017.1349143","article-title":"Preparation and optimization of rivastigmine-loaded tocopherol succinate-based solid lipid nanoparticles","volume":"28","author":"Malekpour-Galogahi","year":"2018","journal-title":"Journal of Liposome Research"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nature Reviews Materials"},{"key":"10.1016\/bs.apha.2026.02.005_bib121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2018.03.002","article-title":"Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting","volume":"282","author":"Mart\u00ednez-Jothar","year":"2018","journal-title":"Journal of Controlled Release"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201900427","article-title":"The effect of ligand mobility on the cellular interaction of multivalent nanoparticles","volume":"20","author":"Maslanka Figueroa","year":"2020","journal-title":"Macromolecular Bioscience"},{"issue":"40","key":"10.1016\/bs.apha.2026.02.005_bib123","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.2174\/1381612823666170913164738","article-title":"The transport mechanism of extracellular vesicles at the blood-brain barrier","volume":"23","author":"Matsumoto","year":"2018","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib124","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1021\/acschemneuro.8b00292","article-title":"In vivo use of a multi-dna aptamer-based payload\/targeting system to study dopamine dysregulation in the central nervous system","volume":"10","author":"McConnell","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.apha.2026.02.005_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100993","article-title":"Revealing macropinocytosis using nanoparticles","volume":"83","author":"Means","year":"2022","journal-title":"Molecular Aspects of Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib126","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1039\/D3LC00821E","article-title":"Microfluidic synthesis of lipid-based nanoparticles for drug delivery: Recent advances and opportunities","volume":"24","author":"Mehraji","year":"2024","journal-title":"Lab on a Chip"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.005_bib127","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: An overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Materials Au"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nature Reviews Methods Primers"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1039\/D1TB02015C","article-title":"Influence of nanoparticle size on blood\u2013brain barrier penetration and the accumulation of anti-seizure medicines in the brain","volume":"10","author":"Meng","year":"2022","journal-title":"Journal of Materials Chemistry B"},{"key":"10.1016\/bs.apha.2026.02.005_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtadv.2022.100299","article-title":"Fabrication of active targeting lipid nanoparticles: Challenges and perspectives","volume":"16","author":"Menon","year":"2022","journal-title":"Materials Today Advances"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.apha.2026.02.005_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216220","article-title":"Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes","volume":"565","author":"Moholkar","year":"2023","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-024-02511-7","article-title":"Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands","volume":"22","author":"Moreira","year":"2024","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/bs.apha.2026.02.005_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115446","article-title":"Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome","volume":"214","author":"Mrksich","year":"2024","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib135","first-page":"263","article-title":"Recent patents, regulatory issues, and toxicity of nanoparticles in neuronal disorders","volume":"22","author":"Muheem","year":"2020","journal-title":"Current Drug Metabolism"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib136","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/ma15020682","article-title":"Synthesis and potential applications of lipid nanoparticles in medicine","volume":"15","author":"Musielak","year":"2022","journal-title":"Materials"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib137","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/ijms24010787","article-title":"Nanoparticles in clinical trials: Analysis of clinical trials, FDA approvals and use for COVID-19 vaccines","volume":"24","author":"Namiot","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.005_bib138","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/ph16111583","article-title":"Comparative analysis of the physicochemical and biological characteristics of freeze-dried pegylated cationic solid lipid nanoparticles","volume":"16","author":"Narv\u00e1ez-Narv\u00e1ez","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib139","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: Structure preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/jnt3020006","article-title":"Lipid nanoparticles as platforms for theranostic purposes: Recent advances in the field","volume":"3","author":"Naziris","year":"2022","journal-title":"Journal of Nanotheranostics"},{"key":"10.1016\/bs.apha.2026.02.005_bib141","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jbiotec.2021.03.010","article-title":"Transferrin-functionalized lipid nanoparticles for curcumin brain delivery","volume":"331","author":"Neves","year":"2021","journal-title":"Journal of Biotechnology"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.005_bib142","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1021\/acs.bioconjchem.8b00285","article-title":"In vivo translation of peptide-targeted drug delivery systems discovered by phage display","volume":"29","author":"Newman","year":"2018","journal-title":"Bioconjugate Chemistry"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/ph18050615","article-title":"Advancements in nanocarrier systems for nose-to-brain drug delivery","volume":"18","author":"Nguyen","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib144","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/nano11040864","article-title":"Nanomaterials synthesis through microfluidic methods: An updated overview","volume":"11","author":"Niculescu","year":"2021","journal-title":"Nanomaterials"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.rpor.2018.05.005","article-title":"Formation of a protein corona influences the biological identity of nanomaterials","volume":"23","author":"Nierenberg","year":"2018","journal-title":"Reports of Practical Oncology and Radiotherapy"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib146","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ymthe.2024.03.004","article-title":"Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke","volume":"32","author":"Nong","year":"2024","journal-title":"Molecular Therapy"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib147","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/08982104.2023.2226216","article-title":"Liposome bilayer stability: Emphasis on cholesterol and its alternatives","volume":"34","author":"Nsairat","year":"2024","journal-title":"Journal of Liposome Research"},{"issue":"17","key":"10.1016\/bs.apha.2026.02.005_bib148","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood\u2013brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem Soc Rev"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.005_bib149","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/molecules30071572","article-title":"Peptide-functionalized nanomedicine: Advancements in drug delivery, diagnostics, and biomedical applications","volume":"30","author":"Omidian","year":"2025","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2016.06.116","article-title":"Determination of the activity of maleimide-functionalized phospholipids during preparation of liposomes","volume":"514","author":"Oswald","year":"2016","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib151","first-page":"17","article-title":"A recent update: Solid lipid nanoparticles for effective drug delivery","volume":"12","author":"Pandey","year":"2021","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"10.1016\/bs.apha.2026.02.005_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: Physiology and strategies for drug delivery","volume":". 165\u2013166","author":"Pandit","year":"2020","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.apha.2026.02.005_bib153","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biomaterials.2017.09.020","article-title":"Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery","volume":"147","author":"Parodi","year":"2017","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-024-02749-2","article-title":"Hot-melt extrusion: From theory to application in pharmaceutical formulation\u2014Where are we now?","volume":"25","author":"Patil","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2026.02.005_bib155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hum.2023.29263.bfs","article-title":"CASGEVY makes history as FDA approves first CRISPR\/Cas9 genome edited therapy","volume":"35","author":"Philippidis","year":"2024","journal-title":"Human Gene Therapy"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.005_bib156","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02865-1","article-title":"RVG29-functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer\u2019s disease","volume":"37","author":"Pinheiro","year":"2020","journal-title":"Pharmaceutical Research"},{"issue":"45","key":"10.1016\/bs.apha.2026.02.005_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903156","article-title":"On the structure of solid lipid nanoparticles","volume":"15","author":"Pink","year":"2019","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/bs.apha.2026.02.005_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114197","article-title":"Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids","volume":"184","author":"Prakash","year":"2022","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.005_bib159","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jpp\/rgad089","article-title":"Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines","volume":"76","author":"Puccetti","year":"2024","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"26","key":"10.1016\/bs.apha.2026.02.005_bib160","doi-asserted-by":"crossref","first-page":"29037","DOI":"10.1021\/acsami.0c05556","article-title":"Hybrid magnetic nanovectors promote selective glioblastoma cell death through a combined effect of lysosomal membrane permeabilization and chemotherapy","volume":"12","author":"Pucci","year":"2020","journal-title":"ACS Applied Materials and Interfaces"},{"key":"10.1016\/bs.apha.2026.02.005_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114962","article-title":"Evolution of nanomedicine formulations for targeted delivery and controlled release","volume":"200","author":"Puri","year":"2023","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib162","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-01180-0","article-title":"Combined integrin \u03b1v\u03b23 and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect","volume":"19","author":"Qi","year":"2021","journal-title":"J Nanobiotechnology"},{"issue":"44","key":"10.1016\/bs.apha.2026.02.005_bib163","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.2174\/0113816128279248231210172053","article-title":"Review on the artificial intelligence-based nanorobotics targeted drug delivery system for brain-specific targeting","volume":"29","author":"Rai","year":"2023","journal-title":"Current Pharmaceutical Design"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.005_bib164","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1039\/C7SC00732A","article-title":"Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma","volume":"8","author":"Rajora","year":"2017","journal-title":"Chemical Science"},{"key":"10.1016\/bs.apha.2026.02.005_bib165","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jconrel.2023.05.001","article-title":"Design of experiments in the optimization of nanoparticle-based drug delivery systems","volume":"358","author":"Rampado","year":"2023","journal-title":"Journal of Controlled Release"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.005_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-019-2692-6","article-title":"Quality-by-design concepts to improve nanotechnology-based drug development","volume":"36","author":"Rawal","year":"2019","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/bs.apha.2026.02.005_bib167","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3762\/bjoc.17.75","article-title":"Enhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides","volume":"17","author":"Ray","year":"2021","journal-title":"Beilstein Journal of Organic Chemistry"},{"issue":"17","key":"10.1016\/bs.apha.2026.02.005_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500844","article-title":"Optimization of lipid nanoparticles with robust efficiency for the delivery of protein therapeutics to augment cancer immunotherapy","volume":"12","author":"Ren","year":"2025","journal-title":"Advanced Science"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.005_bib169","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/pharmaceutics12111095","article-title":"Manufacturing considerations for the development of lipid nanoparticles using microfluidics","volume":"12","author":"Roces","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105916","article-title":"Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept","volume":"164","author":"Rojekar","year":"2021","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib171","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tips.2019.10.009","article-title":"Oligonucleotides to the (Gene) rescue: FDA approvals 2017\u20132019","volume":"41","author":"R\u00fcger","year":"2020","journal-title":"Trends in Pharmacological Sciences"},{"issue":"17\u201318","key":"10.1016\/bs.apha.2026.02.005_bib172","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/hum.2024.106","article-title":"Lipid nanoparticles for nucleic acid delivery beyond the liver","volume":"35","author":"Saber","year":"2024","journal-title":"Human Gene Therapy"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib173","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.3390\/pharmaceutics14091874","article-title":"Peptide shuttles for blood\u2013brain barrier drug delivery","volume":"14","author":"S\u00e1nchez-Navarro","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587012","article-title":"Nanoparticle surface functionalization: How to improve biocompatibility and cellular internalization","volume":"7","author":"Sanit\u00e0","year":"2020","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.005_bib175","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","article-title":"Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB","volume":"13","author":"Satapathy","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib176","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jconrel.2024.05.006","article-title":"The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting","volume":"370","author":"Sato","year":"2024","journal-title":"Journal of Controlled Release"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioengineering and Translational Medicine"},{"key":"10.1016\/bs.apha.2026.02.005_bib178","article-title":"Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-synuclein aggregation and improve behavioral symptoms in Parkinson\u2019s disease","author":"Sela","year":"2023","journal-title":"Advanced Materials"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.005_bib179","first-page":"2088","article-title":"Nose to brain transport pathways an overview: Potential of nanostructured lipid carriers in nose to brain targeting","volume":"46","author":"Selvaraj","year":"2018","journal-title":"Artificial Cells, Nanomedicine and Biotechnology"},{"issue":"32","key":"10.1016\/bs.apha.2026.02.005_bib180","doi-asserted-by":"crossref","first-page":"25910","DOI":"10.1039\/D5RA03578C","article-title":"Precision targeting of the CNS: Recent progress in brain-directed nanodrug delivery","volume":"15","author":"Senanayake","year":"2025","journal-title":"RSC Advances"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib181","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/pharmaceutics15030772","article-title":"Recent progress of lipid nanoparticles-based lipophilic drug delivery: Focus on surface modifications","volume":"15","author":"Seo","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.005_bib182","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib183","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/2211738506666180611100416","article-title":"Lipid nanoparticles: A novel approach for brain targeting","volume":"6","author":"Shankar","year":"2018","journal-title":"Pharmaceutical Nanotechnology"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib184","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/d41587-023-00016-6","article-title":"The world\u2019s first CRISPR therapy is approved: Who will receive it?","volume":"42","author":"Sheridan","year":"2024","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.apha.2026.02.005_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114849","article-title":"Blood brain barrier-targeted lipid nanoparticles improved the neuroprotection of Ferrostatin-1 against cerebral ischemic damage in an experimental stroke model","volume":"379","author":"Shi","year":"2024","journal-title":"Experimental Neurology"},{"issue":"17","key":"10.1016\/bs.apha.2026.02.005_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176070","article-title":"Nanoparticle-based technology approaches to the management of neurological disorders","volume":"21","author":"Sim","year":"2020","journal-title":"In International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2026.02.005_bib187","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","article-title":"Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies \u2013 challenges and opportunities","volume":"370","author":"Simonsen","year":"2024","journal-title":"Journal of Controlled Release"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.005_bib188","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/acschemneuro.1c00087","article-title":"Emerging application of nanorobotics and artificial intelligence to cross the BBB: Advances in design, controlled maneuvering, and targeting of the barriers","volume":"12","author":"Singh","year":"2021","journal-title":"ACS Chemical Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib189","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/1061186X.2015.1068320","article-title":"Lactoferrin bioconjugated solid lipid nanoparticles: A new drug delivery system for potential brain targeting","volume":"24","author":"Singh","year":"2016","journal-title":"Journal of Drug Targeting"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/10611860600650086","article-title":"Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies","volume":"14","author":"Smith","year":"2006","journal-title":"Journal of Drug Targeting"},{"issue":"44","key":"10.1016\/bs.apha.2026.02.005_bib191","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401445","article-title":"Tuning lipid nanoparticles for RNA delivery to extrahepatic organs","volume":"36","author":"Song","year":"2024","journal-title":"Advanced Materials"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.005_bib192","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1039\/C7CS00877E","article-title":"Peptide and protein nanoparticle conjugates: Versatile platforms for biomedical applications","volume":"47","author":"Spicer","year":"2018","journal-title":"Chemical Society Reviews"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib193","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1021\/acsanm.8b01239","article-title":"Nanoparticle manufacturing-heterogeneity through processes to products","volume":"1","author":"Stavis","year":"2018","journal-title":"ACS Applied Nano Materials"},{"key":"10.1016\/bs.apha.2026.02.005_bib194","article-title":"Directing the way\u2014Receptor and chemical targeting strategies for nucleic acid delivery","author":"Steffens","year":"2022","journal-title":"Pharmaceutical Research"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11095-022-03385-w","article-title":"Directing the way-receptor and chemical targeting strategies for nucleic acid delivery","volume":"40","author":"Steffens","year":"2023","journal-title":"Pharmaceutical Research"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib196","first-page":"465","article-title":"Challenges in carrier-mediated intracellular delivery: Moving beyond endosomal barriers","volume":"8","author":"Stewart","year":"2016","journal-title":"Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/bs.apha.2026.02.005_bib197","unstructured":"Strazielle,\u00a0N., &\u00a0Ghersi-Egea,\u00a0J.-F. (2016).\u00a0Bentham science no.\u00a0doi:\u00a010.2174\/138161282266616072."},{"issue":"6","key":"10.1016\/bs.apha.2026.02.005_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-020-04848-0","article-title":"Optimization of nanostructured lipid carriers: Understanding the types, designs, and parameters in the process of formulations","volume":"22","author":"Subramaniam","year":"2020","journal-title":"Journal of Nanoparticle Research"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.apha.2026.02.005_bib200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"From physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiological Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib201","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3642","article-title":"Surface modification of lipid nanoparticles for gene therapy","volume":"26","author":"Tafech","year":"2024","journal-title":"Journal of Gene Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acs.chemrev.1c00484","article-title":"Click and bioorthogonal chemistry: The future of active targeting of nanoparticles for nanomedicines?","volume":"122","author":"Taiariol","year":"2022","journal-title":"Chemical Reviews"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.005_bib203","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3390\/molecules26092694","article-title":"Solid lipid nanoparticles produced via a coacervation method as promising carriers for controlled release of quercetin","volume":"26","author":"Talarico","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib204","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/pharmaceutics5030498","article-title":"Advances in lipid nanoparticles for siRNA delivery","volume":"5","author":"Tam","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib205","first-page":"1","article-title":"Peptide-functionalized nanoparticles for brain-targeted therapeutics","author":"Tang","year":"2025","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/bs.apha.2026.02.005_bib206","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejpb.2020.01.005","article-title":"Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases","volume":"149","author":"Teixeira","year":"2020","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.005_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112999","article-title":"Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases","volume":"221","author":"Teixeira","year":"2023","journal-title":"Colloids and Surfaces. B, Biointerfaces"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.005_bib208","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib209","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40005-022-00607-6","article-title":"Nanomedicine-based commercial formulations: Current developments and future prospects","volume":"53","author":"Thapa","year":"2022","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.005_bib210","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acschembio.5c00039","article-title":"Optimizing Peptide-Conjugated Lipid Nanoparticles for Efficient siRNA Delivery across the Blood\u2013Brain Barrier and Treatment of Glioblastoma Multiforme","volume":"20","author":"Tong","year":"2025","journal-title":"ACS Chem Biol"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib211","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17425247.2020.1698544","article-title":"Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier","volume":"17","author":"Tosi","year":"2019","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/bs.apha.2026.02.005_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110537","article-title":"Surface functionalized nanoparticles: A boon to biomedical science","volume":"380","author":"Upadhyay","year":"2023","journal-title":"Chemico-Biological Interactions"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib213","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40120-020-00208-1","article-title":"A review of patisiran (ONPATTRO\u00ae) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis","volume":"9","author":"Urits","year":"2020","journal-title":"Neurology and Therapy"},{"key":"10.1016\/bs.apha.2026.02.005_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213125","article-title":"Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy","volume":"141","author":"van den Broek","year":"2022","journal-title":"Biomaterials Advances"},{"key":"10.1016\/bs.apha.2026.02.005_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124686","article-title":"The piper at the gates of brain: A systematic review of surface modification strategies on lipid nanoparticles to overcome the blood-brain-barrier","volume":"665","author":"Vargas","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib216","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.5599\/admet.2988","article-title":"Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies: Review paper","volume":"13","author":"Vargas","year":"2025","journal-title":"ADMET and DMPK"},{"issue":"March","key":"10.1016\/bs.apha.2026.02.005_bib217","article-title":"Dialysis is a key factor modulating interactions between critical process parameters during the microfluidic preparation of lipid nanoparticles","volume":"54","author":"Vargas","year":"2023","journal-title":"Colloids and Interface Science Communications"},{"key":"10.1016\/bs.apha.2026.02.005_bib218","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2023.02.010","article-title":"Targeted nanomedicine: Lessons learned and future directions","volume":"355","author":"Veiga","year":"2023","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.apha.2026.02.005_bib219","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.colsurfb.2016.05.037","article-title":"Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of vitamin E TPGS coated trans resveratrol liposomes","volume":"145","author":"Vijayakumar","year":"2016","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"10.1016\/bs.apha.2026.02.005_bib220","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","author":"Voke","year":"2025","journal-title":"bioRxiv [Preprint]"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib221","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11050210","article-title":"Nanomedicines for the delivery of biologics","volume":"11","author":"Wahlich","year":"2019","journal-title":"Pharmaceutics"},{"issue":"15","key":"10.1016\/bs.apha.2026.02.005_bib222","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1039\/D1RA00550B","article-title":"Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system","volume":"11","author":"Wang","year":"2021","journal-title":"RSC Advances"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib223","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2022","journal-title":"Nature Protocols"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib224","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nature Protocols"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.005_bib225","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1080\/17425247.2023.2245332","article-title":"Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood\u2013brain barrier","volume":"20","author":"Wei","year":"2023","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib226","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biotechadv.2019.04.012","article-title":"RNAi therapeutic and its innovative biotechnological evolution","volume":"37","author":"Weng","year":"2019","journal-title":"Biotechnology Advances"},{"key":"10.1016\/bs.apha.2026.02.005_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103553","article-title":"Lipid nanoparticles in the development of mRNA vaccines for COVID-19","volume":"74","author":"Wilson","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib228","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12554-2","article-title":"Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide","volume":"10","author":"Wu","year":"2019","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/bs.apha.2026.02.005_bib229","doi-asserted-by":"crossref","DOI":"10.3390\/nano13233004","article-title":"Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders","volume":"13","author":"Wu","year":"2023","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.apha.2026.02.005_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.135682","article-title":"Enhancing the stability, BBB permeability and neuroprotective activity of verbascoside in vitro using lipid nanocapsules in combination with menthol","volume":"414","author":"Wu","year":"2023","journal-title":"Food Chemistry"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.005_bib232","doi-asserted-by":"crossref","first-page":"15627","DOI":"10.1021\/acsnano.2c05317","article-title":"How nanoparticles open the paracellular route of biological barriers: Mechanisms, applications, and prospects","volume":"16","author":"Wu","year":"2022","journal-title":"ACS Nano"},{"issue":"52","key":"10.1016\/bs.apha.2026.02.005_bib233","doi-asserted-by":"crossref","first-page":"32549","DOI":"10.1039\/D1RA04293A","article-title":"Regulation of microglia polarization: Via mannose receptor-mediated delivery of siRNA by ligand-functionalized DoGo LNP","volume":"11","author":"Xiao","year":"2021","journal-title":"RSC Advances"},{"key":"10.1016\/bs.apha.2026.02.005_bib234","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1214450","article-title":"Lipid-based nanoparticles via nose-to-brain delivery: A mini review","volume":"11","author":"Xinchen","year":"2023","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib235","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1021\/acsnano.2c02347","article-title":"Surface modification of lipid-based nanoparticles","volume":"16","author":"Xu","year":"2022","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.005_bib236","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Advanced NanoBiomed Research"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.005_bib237","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03540-6","article-title":"Brain targeted lipid nanoparticles with Hv1 inhibitors alleviate neuroinflammation post-ischemic stroke","volume":"23","author":"Yang","year":"2025","journal-title":"Journal of Nanobiotechnology"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.005_bib238","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nnano.2010.141","article-title":"Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer","volume":"5","author":"Yang","year":"2010","journal-title":"Nature Nanotechnology"},{"issue":"44","key":"10.1016\/bs.apha.2026.02.005_bib239","doi-asserted-by":"crossref","first-page":"29977","DOI":"10.1021\/acsami.6b10146","article-title":"Liposome-Based Systemic Glioma-Targeted Drug Delivery Enabled by All-d Peptides","volume":"8","author":"Ying","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/bs.apha.2026.02.005_bib240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbrc.2022.04.080","article-title":"Enhancement of cerebroprotective effects of lipid nanoparticles encapsulating FK506 on cerebral ischemia\/reperfusion injury by particle size regulation","volume":"611","author":"Yoneda","year":"2022","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.005_bib241","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40005-013-0087-y","article-title":"Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): Recent advances in drug delivery","volume":"43","author":"Yoon","year":"2013","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.005_bib242","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/biom13101497","article-title":"Enabling mRNA therapeutics: Current landscape and challenges in manufacturing","volume":"13","author":"Youssef","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/bs.apha.2026.02.005_bib243","doi-asserted-by":"crossref","DOI":"10.1039\/D4NR04778H","article-title":"Recent advances in functional lipid-based nanomedicines as drug carriers for organ-specific delivery","author":"Yun","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/bs.apha.2026.02.005_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103207","article-title":"A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review","volume":"70","author":"Zagalo","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/bs.apha.2026.02.005_bib245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","article-title":"The barrier and interface mechanisms of the brain barrier, and brain drug delivery","volume":"190","author":"Zhang","year":"2022","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.apha.2026.02.005_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2025.07.014","article-title":"A novel dual-targeting strategy of nanobody-driven protein corona modulation for glioma therapy","author":"Zhang","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"38","key":"10.1016\/bs.apha.2026.02.005_bib247","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202425165","article-title":"Optimizing Angiopep-2 density on polymeric nanoparticles for enhanced blood\u2013brain barrier penetration and glioblastoma targeting: Insights from in vitro and in vivo experiments","volume":"35","author":"Zhang","year":"2025","journal-title":"Advanced Functional Materials"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.005_bib248","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/1061186X.2023.2216405","article-title":"Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer\u2019s disease-related symptoms in APP\/PS-1 mice","volume":"31","author":"Zhang","year":"2023","journal-title":"J Drug Target"},{"key":"10.1016\/bs.apha.2026.02.005_bib249","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.978513","article-title":"Applications of nanobodies in brain diseases","volume":"13","author":"Zheng","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib250","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10395","article-title":"Targeted brain delivery of RVG29\u2010modified rifampicin\u2010loaded nanoparticles for Alzheimer\u2019s disease treatment and diagnosis","volume":"7","author":"Zhou","year":"2022","journal-title":"Bioeng Transl Med"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.005_bib251","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030388","article-title":"Targeting neuroinflammation in central nervous system diseases by oral delivery of lipid nanoparticles","volume":"17","author":"Zou","year":"2025","journal-title":"Pharmaceutics"}],"container-title":["Advances in Pharmacology","Brain Shuttle Peptides: Development and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:21:41Z","timestamp":1782854501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358926000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443415470"],"references-count":251,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2026.02.005","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}